Treatment of uremic hyperparathyroidism with percutaneous ethanol injection

Nephron - Clinical Practice

Volumn 101, Issue 2, 2005, Pages

  Fassi, Juliana ^a   Lambertini, Roberto ^a   Farias, Patricia ^a   Blejman, Oscar ^a   Rosa Diez, Guillermo ^a   Algranati, Salomon ^a   Plantalech, Luisa ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Chronic renal failure; Dialysis; Hyperparathyroidism; Parathyroidectomy; Percutaneous ethanol injection

Indexed keywords

ALCOHOL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIALYSIS; ECHOGRAPHY; FEMALE; HEMATOMA; HUMAN; HYPOCALCEMIA; MALE; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SAMPLE SIZE; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; VOCAL CORD PARALYSIS;

ADULT; ETHANOL; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INJECTIONS; KIDNEY FAILURE, CHRONIC; MALE; UREMIA;

EID: 23944480864     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086222     Document Type: Article

References (21)

1. Slatopolsky E, Dusso A: Pathogenesis of secondary hyperparathyroidism. Kidney Int 1999;56(suppl 73):14-19.
2. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Marion KJ: Marked suppression of secondary hyperparatkyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984;74:2136-2143.
3. Rodriguez-Garcia M, Fernandez-Martín JL, Ruiz de Castañeda J, Hervás-Sanchez J, Cannata-Andía JB, Caldial Study Group: Advantages of adjusting the initial dose of intravenous calcitriol according to PTH levels. Kidney Int 2003;63(suppl 85):79-82.
4. 3 on secondary hyperparathyroidism in haemodialysis patients. One-year administration study. Nephrol Dial Transplant 2002;17(suppl 10):28-36.
5. Llach F, Yudd M: Paracalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. Am J Kidney Dis 2001;38(suppl 5):S45-S50.
6. Fukagawa M, Kitaoka M, Kurokawa K: Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: A theoretical approach. Nephrol Dial Transplant 1996;11(suppl 3):125-129.
7. Solbiati L, Giangrande A, De Para L, Bellotti E, Cantu P, Ravetto C: Percutaneous ethanol injection of parathyroid tumors under US guidance: Treatment for secondary hyperparathyroidism. Radiology 1985;155:607-610.
8. Kukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kakuta T, Onoda N, Koiwa F, Yumita S, Kurokawa K: Guidelines for percutaneous ethanol injection therapy of parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 2003;18(suppl 3):31-33.
9. Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kurokawa K: Selective percutaneous ethanol injection therapy of the parathyroid in chronic dialysis patients - The Japanese strategy. Nephrol Dial Transplant 1999;14:2574-2577.
10. Giangrande A, Castiglioni A, Solbiati L, Ballarati R, Caligara F: Chemical parathyroidectomy for recurrence of secondary hyperparathyroidism. Am J Kidney Dis 1994;24:3:421-426.
11. Giangrande A, Castiglioni A, Solbiati L, Allaria P: Ultrasound-guided percutaneous fine needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992;7:412-421.
12. Tanaka R, Kakuta T, Fujisaki T, Tanaka S, Sakai H, Kurokawa K, Saito A: Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography. Nephrol Dial transplant 2003;18(suppl 3):58-61.
13. National Kidney Foundation K/DOQI: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(suppl 3):S1-S202.
14. Fukagawa M, Nakanishi S: Role of parathyroid intervention in the management of secondary hyperparathyroidism. Nephrol Dial Transplant 2003;18(suppl 3):23-26.
15. Onoda N, Kurihara S, Sakurai Y, Owada K, Osono E, Adachi H, Suga M, Yoneshima H: Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology Nephrol Dial Transplant 2003;18(suppl 3):34-37.
16. Kakuta T, Tadaki F, Fujisaki T, Noguchi M, Abe Y, Sakai H, Kurokawa K, Saito A: Long-term prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Biomed Pharmacother 2000;54(suppl 1):60-65.
17. Nakamura M, Fuchinoue S, Teraoka S: Clinical experience with percutaneous ethanol injection therapy in haemodialysis patients with renal hyperparathyroidism. Am J Kidney Dis 2003;42:739-745.
18. Douthat WG, Orozco SE, de Arteaga J, Massari P: Treatment of refractory hyperparathyroidism with ethanol injection: The importance of glandular volume. Kidney Int 2003;63(suppl 85):S101-S104.
19. Cintin C, Karstrup S, Ladefoged SD, Joffe P: Terciary hyperparathyroidism treated by ultrasonically guided percutaneous fine needle ethanol injection. Nephron 1994;68:217-220.
20. Fletcher S, Kanagasundaram NS, Rayner HC, Irving HC, Fowler RC, Brownjohn AM, Turney JH, Will EJ, Davison AM: Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephron Dial Transplant 1998;13:3111-3117.
21. Kitoaka M: Ultrasonographic diagnosis of parathyroid glands and percutaneous ethanol injection therapy. Nephrol Dial Transplant 2003;18(suppl 3):27-30.